Search results
Down 57%, Is AbCellera Biologics a Buy on the Dip?
Motley Fool via Yahoo Finance· 4 days agoIs AbCellera a good investment now? There's a chance that one or more of AbCellera's partnered programs can succeed and drive the stock to its previous...
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Motley Fool via Yahoo Finance· 1 day agoIn other words, this stock has good odds of rising, and a competitor entering the scene won't...
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street |...
The Motley Fool· 7 hours agoSummit Therapeutics (SMMT -4.17%) is sizzling hot this year, with its shares skyrocketing around...
We're Interested To See How Coast Entertainment Holdings (ASX:CEH) Uses Its Cash Hoard To Grow
Simply Wall St. via Yahoo Finance· 7 days agoFor us, it's always important to consider risks around cash burn rates. But investors should look at...
Could Structure Therapeutics Become the Next Novo Nordisk? | The Motley Fool
The Motley Fool· 3 hours agoWhile the pre-revenue biotech is still a fledgling in the midst of its attempt to develop its first...
Payout Powerhouses: 7 Dividend Stocks to Buy Now
InvestorPlace· 4 days agoAlthough growth ideas will probably always attract the market’s attention, it’s useful to balance your holdings with dividend stocks to buy.
‘Load Up,’ Says Goldman Sachs About These 2 Strong Buy Stocks
TipRanks via Yahoo Finance· 6 days agoStock picking is going to get a bit more difficult in the near term, if the word coming out of...
Big Warren Buffett Purchase Highlights Recent Insider Buying
247wallst.com· 1 day agoWarren Buffett has purchased more of his favorite energy stock. Other notable insider buying in the...
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
The Motley Fool via AOL· 1 day agoIn other words, this stock has good odds of rising, and a competitor entering the scene won't immediately change that...if you have them, and, if you're ...
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Purchased by Syon Capital LLC
ETF DAILY NEWS· 11 hours agoSyon Capital LLC increased its holdings in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) by 10.6% in the fourth quarter, Holdings Channel reports. The firm owned 6,741 shares ...